Presentation – iZafe Group

iZafe Group presents at Stora Aktiedagarna

iZafe Group (publ.) hereby announces that CEO Anders Segerström will present on Tuesday, June 11 at 11:45 AM at Stora Aktiedagarna in Stockholm.

On Tuesday, June 11 at 11:45 AM, iZafe will present its business at Stora Aktiedagarna in Stockholm. The address is Birger Jarlsgatan 61 A. The presentation will also be broadcast live and available afterwards on Aktiespararna's YouTube channel as well as on iZafe's website.

More information can be found via this link: https://www.aktiespararna.se/aktiviteter/aktiedagarna-i-stockholm-42149

About iZafe Group AB (publ.)

iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.

The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company's solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.

The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.

iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company's Certified Adviser. Further information is available at www.izafegroup.com

iZafe Group presents at Stora Aktiedagarna

Stora Aktiedagen 1

iZafe Group presented at Stora Aktiedagarna

iZafe Group's CEO, Anders Segerström, presented the company at the Aktiespararna’s event Stora Aktiedagarna on November 29. The presentation was held in Swedish and includes updates on the acquisition of Pilloxa, the significance of winning the procurement in Sweden, and the status of Dosell's existing markets.

You can watch the presentation here.
You can also find this presentation and previous ones here

About iZafe Group AB (publ.)

iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.

iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company's Certified Adviser. Further information is available at www.izafegroup.com

iZafe Group presented at Stora Aktiedagarna

Stora Aktiedagen

iZafe Group presents at the “Stora Aktiedagarna”

iZafe Group (publ.) hereby announces that CEO Anders Segerström will present an investor presentation on Wednesday, November 29th at 4:25 PM at the "Stora Aktiedagarna" in Stockholm.

On Wednesday, November 29th at 4:25 PM, iZafe will present its operations at the "Stora Aktiedagarna" in Stockholm. The address is Birger Jarlsgatan 61 A. The presentation will also be broadcast live in Swedish at https://invitepeople.com/public/events/af87c9f59a/pages/aa3d4312cf and will be available afterwards on the Youtube channel of Aktiespararna as well as on iZafe's website.

Questions can be sent via SMS to the number +46(0) 79-347 98 45.
For more information: https://invitepeople.com/events/af87c9f59a

About iZafe Group AB (publ.)

iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.

iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company's Certified Adviser. Further information is available at www.izafegroup.com

Anders_Segerstrom

iZafe Group presents at the "Stora Aktiedagarna"

iZafe Group invites shareholders and others to a Q&A session following the publishing of the year-end report

Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with its year-end report. The report will be available to the public on February 19, 2021 at 08.30 (8:30 a.m.) CET. Questions will be answered by Chief Executive Officer Anders Segerström in a video presentation that will be published on the first of March, 2021 on iZafe's website under the heading Investor Relations.

Please send your questions to before 10:00 (10 a.m.) CET on February 22, 2021. You can also use an online form to send your questions. This form is available on iZafe Group's website, Investor Relations page.

About Us

iZafe Group is a Swedish med-tech company that develops and markets medical and digital security solutions to create safer drug handling at home. Our digital medicine dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. Our products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life.

The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: . Further information is available at www.izafegroup.com/investorrelations.

iZafe Group invites shareholders and others to a Q&A session following the publishing of the year-end report